Article Versions Notes

Mohzari Y, Aljobair F, Alrashed A, Asdaq SMB, Alshuraim RA, Asfour SS, Al-Mouqdad MM, Bamogaddam RF, Al-Anazi D, Zeilinger CE, et al. Safety and Efficacy of Daptomycin in Neonates with Coagulase-Negative Staphylococci: Case Series Analysis. Antibiotics. 2021; 10(2):168. https://doi.org/10.3390/antibiotics10020168

Mohzari, Yahya, Fahad Aljobair, Ahmed Alrashed, Syed Mohammed Basheeruddin Asdaq, Renad Abdullah Alshuraim, Suzan Suhail Asfour, Mountasser Mohammad Al-Mouqdad, Reem F. Bamogaddam, Deemah Al-Anazi, Catherine E. Zeilinger, and et al. 2021. "Safety and Efficacy of Daptomycin in Neonates with Coagulase-Negative Staphylococci: Case Series Analysis" Antibiotics 10, no. 2: 168. https://doi.org/10.3390/antibiotics10020168

Mohzari, Y., Aljobair, F., Alrashed, A., Asdaq, S. M. B., Alshuraim, R. A., Asfour, S. S., Al-Mouqdad, M. M., Bamogaddam, R. F., Al-Anazi, D., Zeilinger, C. E., Alamer, A., Alhassan, B. M., & Sreeharsha, N. (2021). Safety and Efficacy of Daptomycin in Neonates with Coagulase-Negative Staphylococci: Case Series Analysis. Antibiotics, 10(2), 168. https://doi.org/10.3390/antibiotics10020168